|
Market Closed -
Nasdaq
21:00:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 5.770 USD | -3.83% |
|
+0.87% | -50.47% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 574M 495M 466M 424M 798M 54.46B 802M 5.5B 2.14B 27.7B 2.15B 2.11B 91.85B | P/E 2026 * |
-3.16x | P/E 2027 * | -6.87x |
|---|---|---|---|---|---|
| Enterprise Value | 574M 495M 466M 424M 798M 54.46B 802M 5.5B 2.14B 27.7B 2.15B 2.11B 91.85B | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 2.93x |
| Free-Float |
83.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : ARS Pharmaceuticals, Inc.
| 1 day | -3.83% | ||
| 1 week | +0.87% | ||
| Current month | -3.83% | ||
| 1 month | +12.48% | ||
| 3 months | -38.81% | ||
| 6 months | -37.82% | ||
| Current year | -50.47% |
| 1 week | 5.62 |  | 6.12 |
| 1 month | 4.91 | | 6.58 |
| Current year | 4.91 | | 13.15 |
| 1 year | 4.91 | | 13.15 |
| 3 years | 2.55 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2015 |
Donn Casale
CEO | Chief Executive Officer | 53 | 06/07/2026 |
Kathleen Scott
DFI | Director of Finance/CFO | 57 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 07/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 31/07/2021 |
Saqib Islam
BRD | Director/Board Member | 56 | 30/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Chief Executive Officer | 898,456 | 0.9048% | ||
| 24/06/26 | Free | Director | 30,000 | 0.0302% | ||
| 02/01/26 | Free | General Counsel | 240,000 | 0.2428% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.83% | +0.87% | -50.34% | -18.85% | 597M | |
| +0.21% | -2.69% | +1.19% | +17.32% | 49.81B | |
| +2.09% | -0.71% | +452.73% | +498.77% | 44.06B | |
| -1.09% | -0.41% | +35.40% | +15.17% | 42.99B | |
| -0.26% | -4.71% | +17.19% | +71.67% | 40.88B | |
| -0.48% | -0.84% | +16.25% | +49.80% | 33.11B | |
| -1.81% | -5.02% | +22.65% | +113.24% | 16.58B | |
| -1.06% | +2.87% | - | - | 17.27B | |
| -1.35% | -3.40% | +10.13% | +26.34% | 14.63B | |
| -2.05% | -5.14% | +72.89% | +34.69% | 13.76B | |
| Average | -1.12% | -1.82% | +64.23% | +89.79% | 27.37B | |
| Weighted average by Cap. | -0.51% | -1.87% | +94.63% | +120.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 132M 114M 107M 97.78M 184M 12.55B 185M 1.27B 494M 6.39B 497M 486M 21.18B | 196M 169M 159M 145M 272M 18.57B 274M 1.88B 731M 9.45B 735M 719M 31.33B |
| Net income | -182M -157M -148M -134M -253M -17.27B -254M -1.75B -679M -8.78B -683M -668M -29.12B | -84.64M -73.01M -68.68M -62.57M -118M -8.03B -118M -812M -316M -4.09B -318M -311M -13.55B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | US$5.770 | -3.83% | 1,358,005 |
| 31/08/26 | US$6.000 | +1.87% | 1,984,647 |
| 28/08/26 | US$5.890 | -2.32% | 1,190,271 |
| 27/08/26 | US$6.030 | 0.00% | 1,191,261 |
| 26/08/26 | US$6.030 | +5.42% | 1,163,506 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
